Allarity Therapeutics, Inc. (ALLR) financial statements and ratios from SEC XBRL: revenue $320000.00 (TTM), net margin -3509.7%, revenue growth -40.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $320000.00 |
| Net Margin | -3509.7% |
| Revenue Growth (YoY) | -40.0% |
| EPS Growth (YoY) | -95.0% |
| FCF Growth (YoY) | -16.0% |
| Price / Book | 6.30 |
| Price / Sales | 93.99 |
| FCF Yield | -72.9% |
| Altman Z-Score | -10.04 (distress) |
| Sector P/E (Healthcare) | 21.7 |
ALLR overview · ALLR earnings · ALLR KPIs · ALLR investor relations · ALLR ownership · ALLR peers · ALLR filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.